Quick Answer: Switching from an oral or injectable antipsychotic to Janssen schizophrenia injections may provide a longer-lasting medication option with fewer doses to remember. The transition depends on which medication you currently take, whether you can tolerate risperidone or paliperidone, and which Janssen injection your prescribing clinician recommends.
Experience Structured Living supports adults with schizophrenia who need additional structure around medications, psychiatric appointments, daily routines, and independent living. If you or someone you love is having difficulty maintaining stability with schizophrenia, contact us to learn how our supportive living environment can help.
Try Private Case Management
What Janssen Schizophrenia Injections Are Available?
Janssen schizophrenia injections include Risperdal Consta, Invega Sustenna, Invega Trinza, and Invega Hafyera. Risperdal Consta contains risperidone, while the Invega injections contain paliperidone palmitate.
Risperdal Consta is generally administered every two weeks, while Invega Sustenna is typically monthly. Invega Trinza and Hafyera offer longer dosing intervals, but they are generally used only after treatment has first been established with shorter-acting Invega injections.
Can You Switch From Schizophrenia Pills to a Janssen Injection?
Yes, a prescribing clinician may transition someone from an oral antipsychotic to a Janssen injectable when it is clinically appropriate. The exact process depends on the medication being discontinued and the Janssen schizophrenia injection being started.
For Invega Sustenna, previous oral antipsychotics can generally be gradually discontinued when treatment begins. The standard initiation regimen is designed to establish therapeutic paliperidone concentrations without routine oral antipsychotic supplementation.
Risperdal Consta works differently. Oral risperidone or another antipsychotic is generally continued for three weeks after the first injection because the medication is not released immediately at therapeutic levels.
Do You Need to Try Risperidone or Paliperidone Before Switching to Janssen Schizophrenia Injections?
You may need to establish that you can tolerate risperidone or paliperidone before receiving certain Janssen Pharmaceuticals schizophrenia injections. This is especially important if you have never previously taken either medication.
Before starting Invega Sustenna, current prescribing guidance recommends establishing tolerability with oral paliperidone or oral risperidone for people without previous exposure. Similar tolerability considerations apply when starting Risperdal Consta in someone who has never taken oral risperidone.
Can You Switch From Another Injectable Antipsychotic?
Yes, switching from another long-acting injectable to a Janssen option may be possible, but the timing must be individualized. Your prescriber should consider when you last received your injection, how long it remains active, its dose, and the medication being started.
For patients already at steady state on another long-acting injectable, Invega Sustenna may generally be initiated in place of the next scheduled injection rather than using its usual two-dose initiation regimen. Switching strategies still require clinical judgment because there is no single conversion method that applies to every antipsychotic.
Try Private Case Management
Why Might Your Doctor Recommend a Long-Acting Injectable Antipsychotic from Janssen?
A clinician may recommend Janssen schizophrenia injections when maintaining a consistent daily medication routine has become difficult or when a longer-lasting treatment approach could support medication adherence. Injectable treatment also provides greater certainty about whether a scheduled dose was actually received.
This can be particularly relevant when missed doses have contributed to symptom recurrence. However, an injection is not automatically more appropriate than an oral medication, and the choice should be based on treatment response, side effects, lifestyle, medical history, and individual preferences.
What Should You Discuss Before Making the Switch?
Before switching to a Janssen Pharmaceuticals schizophrenia injection, discuss how well your current medication controls symptoms and what problems you are hoping the new medication will address. Your clinician should also know about previous antipsychotic reactions, other medications, kidney problems, metabolic concerns, movement symptoms, and any history of medication-related side effects.
It is also important to understand exactly how the transition will occur. Ask whether your existing medication will be tapered, stopped immediately, temporarily continued alongside the injection, or replaced when your next injectable dose would normally be due.
What Side Effects Can Occur After Switching to Janssen Schizophrenia Injections?
Side effects can occur after switching because risperidone and paliperidone affect dopamine and other signaling systems throughout the body. Possible effects include sleepiness, movement-related symptoms, weight or metabolic changes, increased prolactin, dizziness, blood pressure changes, and injection-site discomfort.
You also cannot simply stop a longer-lasting medication after it’s been administered. Tell your prescriber promptly about significant new symptoms or side effects rather than changing your medication schedule yourself.
Which Injectable Antipsychotic from Janssen Would You Start With?
Someone new to paliperidone injections would generally start with Invega Sustenna rather than immediately receiving the three- or six-month formulation. Trinza requires adequate previous treatment with Sustenna, while Hafyera requires established treatment with an eligible shorter-duration paliperidone injection.
This progression gives the prescribing team an opportunity to evaluate medication response and tolerability before extending the amount of time between doses.
How Experience Structured Living Supports Schizophrenia Recovery
We help adults with schizophrenia build the daily structure needed to follow an established psychiatric treatment plan. Our supportive housing in North County San Diego focuses on activities of daily living, independent living skills, private case management, and work development. We also have a medication management program, if needed.
Our medication management services include reviewing medications during admission and helping residents maintain access to prescriptions and refills. We complement psychiatric care rather than replacing the clinician responsible for prescribing or changing schizophrenia medication.
If you or someone you love is struggling to maintain stability with schizophrenia, contact Experience Structured Living to learn more about our supportive housing and schizophrenia services. We can help provide the structure and day-to-day support needed while you work with your psychiatric providers toward greater independence.
FAQs About Janssen Schizophrenia Injections
Will I feel different immediately after switching to an injectable antipsychotic?
Not necessarily. How quickly you notice changes depends on the medication, your previous treatment, your symptoms, and how the injection's initiated. Discuss expected timing with your prescribing clinician.
Can Janssen schizophrenia injections be stopped if they do not work for me?
Your clinician can discontinue or change treatment, but the medication already injected may continue releasing into your body for an extended period. This makes monitoring response and side effects especially important.
Do Janssen schizophrenia injections require regular appointments?
Yes. Longer dosing intervals reduce how frequently Janssen schizophrenia injections are administered, but psychiatric follow-up is still necessary to monitor symptoms, side effects, physical health, and overall treatment response.
Can I choose an injection just because it lasts longer?
Not always. Eligibility for longer-duration formulations depends on your previous treatment and stability on the medication, so your prescriber must determine which formulation is appropriate.

Dr. Melden earned his Doctorate in Osteopathic Medicine at Philadelphia College Osteopathic Medicine and went to USC Presbyterian Hospital for his residency in Family Medicine. He then completed his Psychiatric residency at the University of California, Irvine and went to UCSD Geropsychiatry pursuing a fellowship. Dr. Melden has over 14 years of experience as a clinician specializing in treating child and adolescent, adult and geriatric clients. He has devoted his life to psychiatry in a variety of different treatment settings including in- patient and out-patient environments. He specializes in the psychiatric evaluation, complementary therapy approaches, and medical management of individuals suffering from mental illness. Currently, he maintains a private practice with Crownview Medical Group in Coronado and Carlsbad, California where he is CEO/President.




